Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Pacific Biosciences of California, Inc. (PACB) had Return on Tangible Equity of 174.40% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$37.15M |
|
$-426.07M |
|
$38.52M |
|
$-1.37M |
|
$466.09M |
|
$-428.93M |
|
$2.56M |
|
$-426.38M |
|
$-426.38M |
|
$-426.07M |
|
$-426.07M |
|
$-426.07M |
|
$-426.07M |
|
$-428.93M |
|
$-42.86M |
|
296.86M |
|
296.86M |
|
$-1.44 |
|
$-1.44 |
|
| Balance Sheet Financials | |
$444.92M |
|
$24.79M |
|
$415.87M |
|
$860.79M |
|
$66.60M |
|
$646.21M |
|
$702.55M |
|
$769.15M |
|
$91.64M |
|
$-244.31M |
|
$91.64M |
|
300.04M |
|
| Cash Flow Statement Financials | |
$-44.06M |
|
$45.23M |
|
$1.96M |
|
$57.59M |
|
$60.73M |
|
$3.14M |
|
$9.20M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.68 |
|
-- |
|
-- |
|
0.88 |
|
7.05 |
|
-3.69% |
|
-1154.51% |
|
-1154.51% |
|
-- |
|
-1147.62% |
|
-1146.81% |
|
$-45.45M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
0.71 |
|
1.17 |
|
76.66 |
|
-464.95% |
|
|
Return on Tangible Equity |
174.40% |
-49.50% |
|
-57.75% |
|
$0.31 |
|
$-0.15 |
|
$-0.15 |
|